Ocugen share price logo

Ocugen

NASDAQ: OCGN

Small Cap

$1.02

+0.02

(+2.00%)

as on

Ocugen Stock Performance

as on October 5, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $1.01
    $1.04
    downward going graph

    0.98%

    Downside

    1.96%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.97
    $2.73
    downward going graph

    4.90%

    Downside

    167.16%

    Upside

    downward going graph

Ocugen share price movements today

Previous Close
$1.00
Open
$1.02
Volume
2.6M
Market Cap
$345.9M
Day's Low - High
$1.01 - $1.04
52 Week Low - High
$0.97 - $2.73

Ocugen Historical Returns

1 Month Return
-25 %
3 Month Return
-32.45 %
1 Year Return
-42.37 %
3 Year Return
+ 146.62 %
5 Year Return
-85.28 %

Ocugen Stock Fundamentals & Key Indicators

Check Ocugen market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$345.9M

EPS (TTM)

-0.2565

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-4.04

Industry PE ratio

-6.25

PEG Ratio

0.19

EBITDA

-70.1M

Revenue (TTM)

4.6M

Profit Margin

100.00%

Return On Equity TTM

1688.22%

Ocugen vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ocugen with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$345.9M-85.28%-4.04100.00%0.00%
StrongBuy$44.3B637.21%-23.320.00%0.00%
Neutral$75.9B-42.79%-23.81-12.57%0.00%
StrongBuy$127.9B185.14%29.1486.04%0.00%
Buy$75.7B33.45%17.5584.86%0.50%

Stock Returns calculator for Ocugen Stock including INR - Dollar returns

The Ocugen stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Ocugen investment value today

Current value as on today

₹62,550

Returns

-₹37,450

(-37.45%)

Returns from Ocugen Stock

-₹42,373 (-42.37%)

Dollar Impact

₹4,923 (+4.92%)

Analyst Recommendation on Ocugen Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Ocugen. Average target price of $12.17

Ocugen Share Price Target

Get share price movements and forecasts by analysts on Ocugen.

What analysts predicted

91.62%UPSIDE

Target Price

$12.17

Current Price

$1.02

Analyzed by

3 Analysts

High

$11

Target

$12.17

Low

$10

Ocugen target price $12.17, a slight upside of 91.62% compared to current price of $1.02. According to 3 analysts rating.

Indian Investors' Interest in Ocugen Stock

Search interest for Ocugen Stock has increased by 308% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:308% versus previous 30 day period

Ocugen Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
1
1
1
0
1
1
1
0
1
1
Gross Profit
1
1
1
0
1
1
1
0
1
1
Operating Income
-12
-15
-13
-13
-14
-13
-17
-16
-17
-16
EBITDA
-11
-14
-12
-13
-13
-12
-17
-15
-17
-19
Interest Expense
-
-
-
-
0
1
1
1
1
4
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-11
-15
-12
-13
-15
-14
-20
-17
-19
-24
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-11
-15
-12
-13
-15
-14
-20
-17
-19
-24
Net Profit Margin
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%

Ocugen Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Mar 2024
Dec 2024
Dec 2025
Total Revenue
-
-
-
0
-
2
6
4
4
Gross Profit
-1
0
-8
-6
-
2
5
2
2
Operating Income
-24
-30
-14
-21
-58
-89
-65
-54
-62
EBITDA
-24
-14
-14
-14
-58
-86
-62
-52
-60
Interest Expense
0
0
1
0
0
-
-
-
5
Depreciation
1
0
0
0
0
0
0
1
2
Income Before Tax
-26
-8
-20
-21
-58
-86
-63
-54
-67
Income Tax Expense
0
-15
-
-
0
-
-
-
-
Net Income
-26
-8
-20
-21
-58
-86
-63
-54
-67
Net Profit Margin
0.00%
0.00%
0.00%
-14676.74%
0.00%
100.00%
88.34%
51.47%
45.86%

Ocugen Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-11
-15
-12
-13
-15
-14
-20
-17
-19
-24
Operating Cash Flow
-10
-9
-11
-10
-19
-10
-12
-13
-21
-12
Investing Cash Flow
-2
0
0
0
0
0
0
0
0
0
Financing Cash Flow
0
0
34
30
-1
0
18
0
34
66
Change in Cash
-13
-10
23
19
-20
-10
5
-13
13
54

Ocugen Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Mar 2024
Dec 2024
Dec 2025
Net Income
-26
-8
-20
-21
-58
-86
-63
-54
-67
Operating Cash Flow
-23
-15
-16
-14
-47
-60
-62
-42
-56
Investing Cash Flow
-1
-1
-2
0
-1
-16
3
-3
0
Financing Cash Flow
0
25
25
31
120
59
20
64
17
Change in Cash
-24
8
5
16
70
-17
-38
19
-39

Global Institutional Holdings in Ocugen

Check out the Institutions with significant holdings in Ocugen.

Funds
Holdings
Vanguard
5.15%
iShares
4.50%
SPDR
4.07%
VANGUARD INDEX FUNDS
3.97%
Thomas E. Claugus
1.03%

Insights on Ocugen

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, OCGN has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 566.9% return, outperforming this stock by 609.3%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, OCGN stock has moved down by -25.0%

About Ocugen

Ocugen, Inc. is a biopharmaceutical company in the clinical development phase, primarily dedicated to pioneering gene therapies aimed at treating various ophthalmic conditions leading to blindness. The company's developmental pipeline features several key candidates: OCU400: An innovative gene therapy designed to reinstate both the function and structural integrity of the retina across a broad spectrum of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and Leber congenital amaurosis. OCU410: Another gene therapy candidate, currently being developed to address dry age-related macular degeneration (AMD). OCU200: A novel fusion protein, presently undergoing preclinical evaluation for its potential in treating diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen maintains significant strategic collaborations, including a partnership with CanSino Biologics Inc. for the joint development and manufacturing of gene therapies, and an alliance with Bharat Biotech for the commercialization of COVAXIN within the United States market. The company's corporate headquarters are situated in Malvern, Pennsylvania.
OrganisationOcugen
Headquarters263 Great Valley Parkway, Malvern, PA, 19355, US
IndustryBiotechnology
CEOShankar Musunuri

Key Management of Ocugen

Name

Title

Mr. Chris Clark

VP of Corporate Communications

Ms. Kristen Craft

Head of People & Culture

Dr. Vijay Tammara Ph.D.

Chief Development Officer

Ms. Jyothy Pillai M.S.

VP & Head of Regulatory & Quality

Dr. Shankar Musunuri M.B.A., Ph.D.

Co-Founder, CEO & Chairman

Dr. Arun Upadhyay Ph.D.

Chief Scientific Officer and Head of Research & Development

Ms. Rita Johnson-Greene M.B.A.

CFO & Principal Accounting Officer

Mr. Paul Staid

Executive Vice President of Operations

John Kouch J.D.

General Counsel

Dr. Mohamed Genead M.D., M.Sc.

Chief Medical Officer

FAQs

What is Ocugen share price today?

Ocugen share price today is $1.02 as on at the close of the market. Ocugen share today touched a day high of $1.04 and a low of $1.01.

What is the 52 week high and 52 week low for Ocugen share?

Ocugen share touched a 52 week high of $2.73 on and a 52 week low of $0.97 on . Ocugen stock price today i.e. is closed at $1.02,which is 62.57% down from its 52 week high and 5.15% up from its 52 week low.

What is Ocugen's market capitalisation today?

Ocugen market capitalisation is $0.00T as on .

How to invest in Ocugen Stock (OCGN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Ocugen on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Ocugen Stock (OCGN) from India?

Indian investors can start investing in Ocugen (OCGN) shares with as little as ₹96.300003051758 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.00 in Ocugen stock (as per the Rupee-Dollar exchange rate as on ). Based on Ocugen share’s latest price of $1.02 as on October 5, 2026 at 8:46 am IST, you will get 9.8039 shares of Ocugen. Learn more about fractional shares .

What are the returns that Ocugen has given to Indian investors in the last 5 years?

Ocugen stock has given -85.28% share price returns and 29.14% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?